Last reviewed · How we verify
[Part 2] IDG-16177
At a glance
| Generic name | [Part 2] IDG-16177 |
|---|
| Sponsor | IlDong Pharmaceutical Co Ltd |
|---|
| Modality | Small molecule |
|---|
| Phase | Phase 1 |
|---|
Approved indications
No approved indications tracked.
Common side effects
No common side effects on file.